RxDoctor Payments Data

Savannah Collins, PA

Medical · Sumter, SCNPI 1932789799

Payments from drug & device makers

$1,774in general payments, 2019–2025

Across 77 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Forte Bio-pharma LLC$755
  • Phathom Pharmaceuticals, Inc.$181
  • AbbVie$170
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$122
  • Viiv Healthcare Company$96
  • Gilead$63
  • plus $387 from 12 others

What the payments were for

  • Food & beverage$1,75399%
  • Education$211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,774 in reported general payments places this provider in the 60th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$13,642
Medicare patients
112
Services billed
179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,168$186,942
RelistorMethylnaltrexone Bromide41$98,924
Xtampza ErOxycodone Myristate61$35,545
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen864$28,407
BelbucaBuprenorphine Hcl26$19,881
OxycontinOxycodone Hcl33$12,118
Naloxone Hcl169$10,469
Oxycodone Hcl379$7,136
Buprenorphine40$6,958
Pregabalin220$3,886
Gabapentin278$3,736
Diclofenac Sodium85$3,075
Lidocaine36$3,040
Morphine Sulfate ErMorphine Sulfate100$2,921
Tizanidine Hcl212$2,291

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$122$98,92441 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$36$55,42587 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$39$7,99472 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 384 medical providers in South Carolina.

Other medical in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →